-

GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists

  • Built for the demands of modern imaging, View streamlines workflows, and helps enhance patient care as the advanced diagnostic viewer powering the Genesis Radiology Workspace

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that View, the powerful viewer within the Genesis™ Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis Radiology Workspace.2 This next‑generation solution aims to transform radiology workflows, unify the user experience, and empower radiologists with greater efficiency and precision.

Studies show that radiologists spend up to 44% of their time on non-interpretive tasks, such as navigating complex interfaces or waiting for images to load—directly impacting productivity and turnaround times.3 Radiologists are looking for solutions that can help them reduce turnaround time and improve their efficiency.

“View is designed to meet radiologists wherever they are—providing secure, high‑performance access to diagnostic imaging through a truly cloud‑native experience,” said Scott Miller, CEO of Solutions for Enterprise Imaging, GE HealthCare. “By removing traditional infrastructure barriers, we’re enabling faster collaboration, greater flexibility, and more streamlined workflows across care teams. View within the Genesis Workspace reflects our commitment to modernizing radiology in ways that support clinicians and, ultimately, improve patient care.”

View is engineered to optimize the radiology workspace by empowering diagnosticians to work from virtually anywhere with full diagnostic confidence. It delivers high‑performance 2D and 3D visualization alongside AI‑enabled tools to support fast, precise clinical decision‑making. In addition, View provides direct access to the full suite of Advanced Visualization applications, enabling seamless, comprehensive analysis within a single workflow.

“This next‑generation viewer will set a new standard—and could offer the ability to complete almost all of a radiologists’ work in a single, streamlined workspace so they can focus on patient care,” said Dr. Laurie Sebastiano.4

This product may not be available in all regions, contact your GE HealthCare sales representative for more information. Visit here to learn more about GE HealthCare’s Genesis solutions.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

____________________

1 Anywhere to state wherever internet is available.

2 Genesis Radiology Workspace consists of View, Enterprise Archive, and Workflow Manager.

3 https://www.sciencedirect.com/science/article/abs/pii/S036301882500194X#sec0007

4 *Dr. Laurie Sebastiano is a compensated member of GE HealthCare’s advisory board. The statements by Dr. Laurie Sebastiano described here are based on their own opinions.

 

Contacts

GE HealthCare Media Contact:
Linh Dinh
Linh.Dinh@gehealthcare.com
M +408 275 5682

GE HealthCare

NASDAQ:GEHC

Release Versions

Contacts

GE HealthCare Media Contact:
Linh Dinh
Linh.Dinh@gehealthcare.com
M +408 275 5682

More News From GE HealthCare

GE HealthCare announces cash dividend increase for third quarter of 2026

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as of October 23, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical dia...

GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership experience across finance, governance, and large-scale technology and digital transformation.“Pascal is a highly respected executive and accomplished financial leader whose...

GE HealthCare Announces CareIntellect for Operations, Helping Health Systems Optimize Resources and Expand Access to Care

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced CareIntellect™ for Operations, a new AI-enabled Software-as-a-Service (SaaS) application designed to help health systems forecast capacity constraints up to 72 hours in advance, providing comprehensive unit-, department-, and enterprise-level views of emerging bottlenecks. By analyzing hundreds of patient- and operational-level data points—including bed availability, patient delays, staffing, wait times, and ancillary servic...
Back to Newsroom